Latest Breaking News On - Initiate pivotal trial - Page 1 : comparemela.com

On Track to Dose the First Patient in the Phase 1 Study Evaluating Belzupacap Sarotalocan (AU‑011) for the Treatment of Non-Muscle Invasive Bladder Cancer in Q3 2022On Track to Initiate Pivotal Trial in Early-Stage Choroidal Melanoma in Q4 2022BOSTON (BUSINESS WIRE) Aura Biosciences Inc. (NASDAQ: AURA), a clinical.

United statesMatthew deyoungLos pinosAura biosciences incAmerican society of clinical oncologyExchange commissionInternational society of ocular oncologyAssociation of researchDivision of oncologyFirst patientEvaluating belzupacap sarotalocanNon muscle invasive bladder cancerInitiate pivotal trialEarly stage choroidal melanomaAura biosciencesElisabet de los pinos